← FDA DRUG APPROVALS

FDA ANDA · ANDA075262

ALBUTEROL SULFATE

Sponsor: ACTAVIS MID ATLANTIC

APPLICATION
ANDA075262
TYPE
ANDA
ORIGINAL APPROVAL
1999-03-30
LATEST ACTION
2001-12-13
ROUTE
ORAL
DOSAGE FORM
SYRUP
MARKETING STATUS
Discontinued

Products

ALBUTEROL SULFATEDiscontinued
ALBUTEROL SULFATE EQ 2MG BASE/5ML · SYRUP · ORAL

Approval history

2001-12-13Manufacturing (CMC) · Supplement 1AP
1999-03-30OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →